Applied Optoelectronics簽訂6億美元股權分銷協議 可按市價發行股份

false
 0001158114
 
 
 
 
 
 
 
 0001158114
 
 
 2026-05-14
 2026-05-14
 
 
 
 iso4217:USD
 
 
 xbrli:shares
 
 
 
 
 iso4217:USD
 
 
 xbrli:shares
 
 
 
 
 

 

 

UNITED STATES

SECURITIES AND
EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of
the

 Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):
May 14, 2026

 

Applied Optoelectronics, Inc.

(Exact name of registrant as specified in its
charter)

 

 
 Delaware
 001-36083
 76-0533927

 
 (State or other jurisdiction of 

incorporation)
 (Commission File
 Number)
 (IRS Employer
 Identification 

No.)

 
 

 13139 Jess Pirtle Blvd.

  

 Sugar Land, Texas 
 77478

 (Address of principal executive offices) 
 (Zip Code)

 

 (281) 295-1800

(Registrant's telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed
since last report)

 

Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

 
 ¨
 Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 
 

 
 ¨
 Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 
 

 
 ¨
 Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 
 

 
 ¨
 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 

Securities registered
pursuant to Section 12(b) of the Act:

 

 
 Title of each class
 Trading Symbol(s)
 Trading Name of each exchange on which 

registered

 
 Common Stock, Par value $0.001
 AAOI
 NASDAQ Global Market

 
 

Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

  

  

 

 

Item 1.01. Entry into a Material Definitive Agreement.

 

On May 14, 2026, Applied Optoelectronics, Inc.
(the “Company”) entered into an Equity Distribution Agreement (the “Agreement”) with Raymond James & Associates,
Inc. and Needham & Company, LLC (collectively, the “Sales Agents”) pursuant to which the Company may issue and sell shares
of the Company’s common stock, par value $0.001 per share (the “Shares”) having an aggregate offering price of up to
$600 million from time to time through the Sales Agents.

 

Upon delivery of a placement notice and subject
to the terms and conditions of the Agreement, sales, if any, of the Shares will be made through the Sales Agents in transactions that
are deemed to be “at the market” offerings as defined in Rule 415 of the Securities Act of 1933, as amended (the “Securities
Act”), including sales made through the facilities of the Nasdaq Global Market, the principal trading market for the Company’s
common stock, on any other existing trading market for the Company’s common stock, to or through a market maker or as otherwise
agreed by the Company and the Sales Agents. In the placement notice, the Company will designate the maximum number of Shares to be sold
through the Sales Agents, the time period during which sales are requested to be made, the minimum price for the Shares to be sold, and
any limitation on the number of Shares that may be sold in any one day. Subject to the terms and conditions of the Agreement, the Sales
Agents will use their commercially reasonable efforts to sell Shares on the Company’s behalf up to the designated amount specified
in the placement notice. The Company has no obligation to sell any Shares under the Agreement and may at any time suspend offers and sales
of the Shares under the Agreement.

 

The Agreement provides that the Sales Agents will
be entitled to compensation of 2% of the gross sales price of the Shares sold through the Sales Agents from time to time. The Company
has also agreed to reimburse the Sales Agents for certain specified expenses in connection with the registration of Shares under state
blue sky laws and any filing with, and clearance of the offering by, the Financial Industry Regulatory Authority Inc., not to exceed $10,000
in the aggregate, and any associated application fees incurred. Additionally, if the Agreement is terminated under certain circumstances,
and the Company fails to sell a minimum amount of the Shares as set forth in the Agreement, then the Company has agreed to reimburse the
Sales Agents for reasonable out-of-pocket expenses, including the reasonable fees and disbursements of counsel incurred by the Sales Agents,
up to a maximum of $30,000 in the aggregate. The Company agreed to indemnify the Sales Agents against certain liabilities, including liabilities
under the Securities Act, or to contribute to payments that the Sales Agents may be required to make because of any of those liabilities.

 

The offering pursuant to the Agreement will terminate
upon the sale of all Shares subject to the Agreement. The Agreement may also be terminated by the Company or by the Sales Agents at any
time.

 

The Shares to be issued and sold have been registered
under the Securities Act, pursuant to the Company’s automatic shelf registration statement on Form S-3ASR (Registration No. 333-283905),
including the prospectus contained therein, as supplemented by the prospectus supplement filed with the Securities and Exchange Commission
(the “SEC”) pursuant to Rule 424(b) under the Securities Act on May 14, 2026.

 

The foregoing description of the Agreement does
not purport to be complete and is qualified in its entirety by reference to the complete text of the Agreement, which is filed as Exhibit
1.1 to this Current Report on Form 8-K and incorporated herein by reference.

 

  

  

 

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

 

 
 Exhibit No.
  
 Description

 
 1.1
  
 Equity Distribution Agreement, dated May 14, 2026, among Applied Optoelectronics, Inc., Raymond James & Associates, Inc., and Needham & Company, LLC.

 
  
  
  

 
 4.1
  
 Common Stock Specimen (incorporated by reference to Exhibit 4.1 of Applied Optoelectronics, Inc’s Form 8-K (File No. 001-36083) filed with the SEC on November 14, 2016).

 
  
  
  

 
 5.1
  
 Opinion of Haynes and Boone, LLP.

 
  
  
  

 
 23.1
  
 Consent of Haynes and Boone, LLP (included in Exhibit 5.1).

 
  
  
  

 
 104
  
 Cover Page Interactive File (the cover page tags are embedded within the Inline XBRL document).

 
 

    

  

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities
Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.

 

 
  
 APPLIED OPTOELECTRONICS, INC.

 
  
  
  

 
 Date: May 14, 2026
 By:
 /s/ David C. Kuo

 
  
 Name:
 David C. Kuo

 
  
 Title:
 Senior Vice President
and Chief Legal Officer